Cornell builds bridges with Qatari 'doctors of the future'

The Ithaca campus and Weill Cornell Medicine-New York welcomed three young guests recently: high school students from Qatar, visiting the United States for the first time to get a sneak peek into the world of academic medicine.

Study looks at diet to assess link of heart disease, metabolite

A Cornell study reports new results that raise questions about whether a common dietary metabolite, called TMAO, causes heart disease or whether it is simply a biomarker of developing disease.

If smoker has COPD, quitting might not help lung function

Quitting cigarettes may not improve smokers' lung function if they have already begun to develop chronic obstructive pulmonary disease, according to new research from Weill Cornell Medicine.

Research links metabolism to inflammatory response

An enzyme that stimulates the breakdown of fats in immune cells helps trigger inflammation, or an immune response to pathogens, a new study by Weill Cornell Medicine researchers suggests.

Nobelists to discuss creativity in science at workshop

Nurturing creativity in science will be explored on July 25 by leading scientists, including two Nobel Prize winners, at the Creativity Spark: a creativity workshop for scientists.

Gil Stoewsand, who helped to save N.Y. wine trade, dies

Gilbert Stoewsand, a Cornell food scientist who helped to rescue New York's fledgling wine industry in the early 1970s by debunking shoddy science that attributed health risks wine made from hybrid grapes, died July 4. He was 83.

Immunologist's book offers blueprint for medical revolution

Rodney Dietert, Cornell professor of immunotoxicology, has penned a new book that calls for a new paradigm in how we view public health and human biology.

Meinig investigator sees lipids as path to curing disease

The key to curing multiple sclerosis may well lie in the mysterious signaling of lipids, a major component of cells, says Cornell chemist Jeremy Baskin.

Recellularized human colon model could aid in cancer research

Cornell researchers have helped develop a recellularized human colon model that could be used to track the pathogenesis of colon cancer and possibly gain insight into its spread to other organs.